109 related articles for article (PubMed ID: 8027984)
1. 3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.
Sheppard GS; Pireh D; Carrera GM; Bures MG; Heyman HR; Steinman DH; Davidsen SK; Phillips JG; Guinn DE; May PD
J Med Chem; 1994 Jun; 37(13):2011-32. PubMed ID: 8027984
[TBL] [Abstract][Full Text] [Related]
2. 2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF).
Nagaoka H; Hara H; Suzuki T; Takahashi T; Takeuchi M; Matsuhisa A; Saito M; Yamada T; Tomioka K; Mase T
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1659-64. PubMed ID: 9353894
[TBL] [Abstract][Full Text] [Related]
3. 2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists.
Suzuki T; Nagaoka H; Kondo Y; Takahashi T; Takeuchi M; Hara H; Saito M; Yamada T; Tomioka K; Hamada M; Mase T
Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1468-73. PubMed ID: 9775441
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
5. Propenyl carboxamide derivatives as antagonists of platelet activating factor.
Guthrie RW; Kaplan GL; Mennona FA; Tilley JW; Kierstead RW; O'Donnell M; Crowley H; Yaremko B; Welton AF
J Med Chem; 1990 Oct; 33(10):2856-64. PubMed ID: 2170651
[TBL] [Abstract][Full Text] [Related]
6. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
Curtin ML; Davidsen SK; Heyman HR; Garland RB; Sheppard GS; Florjancic AS; Xu L; Carrera GM; Steinman DH; Trautmann JA; Albert DH; Magoc TJ; Tapang P; Rhein DA; Conway RG; Luo G; Denissen JF; Marsh KC; Morgan DW; Summers JB
J Med Chem; 1998 Jan; 41(1):74-95. PubMed ID: 9438024
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
8. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationships, and pharmacological evaluation of pyrrolo[3,2,1-ij]quinoline derivatives: potent histamine and platelet activating factor antagonism and 5-lipoxygenase inhibitory properties. Potential therapeutic application in asthma.
Paris D; Cottin M; Demonchaux P; Augert G; Dupassieux P; Lenoir P; Peck MJ; Jasserand D
J Med Chem; 1995 Feb; 38(4):669-85. PubMed ID: 7861415
[TBL] [Abstract][Full Text] [Related]
10. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the activity of a platelet activating factor antagonist, CV-3988.
Hayashi M; Kimura J; Oh-Ishi S; Tsushima S; Nomura H
Jpn J Pharmacol; 1987 Jun; 44(2):127-34. PubMed ID: 2888915
[TBL] [Abstract][Full Text] [Related]
12. (Pyridylcyanomethyl)piperazines as orally active PAF antagonists.
Carceller E; Almansa C; Merlos M; Giral M; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1992 Oct; 35(22):4118-34. PubMed ID: 1433215
[TBL] [Abstract][Full Text] [Related]
13. Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor.
Guthrie RW; Kaplan GL; Mennona FA; Tilley JW; Kierstead RW; Mullin JG; LeMahieu RA; Zawoiski S; O'Donnell M; Crowley H
J Med Chem; 1989 Aug; 32(8):1820-35. PubMed ID: 2754709
[TBL] [Abstract][Full Text] [Related]
14. Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.
Trova MP; Wissner A; Carroll ML; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Kohler CA
J Med Chem; 1993 Mar; 36(5):580-90. PubMed ID: 8496938
[TBL] [Abstract][Full Text] [Related]
15. Thiazolyl/oxazolyl formazanyl indoles as potent anti-inflammatory agents.
Singh N; Bhati SK; Kumar A
Eur J Med Chem; 2008 Nov; 43(11):2597-609. PubMed ID: 18289736
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofurans.
Favre E; Heymans F; Redeuilh C; Batt JP; Massicot F; Blavet N; Braquet P; Godfroid JJ
J Lipid Mediat; 1992 Feb; 5(1):23-40. PubMed ID: 1449553
[TBL] [Abstract][Full Text] [Related]
17. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor.
Grue-Sørensen G; Nielsen IM; Nielsen CK
J Med Chem; 1988 Jun; 31(6):1174-8. PubMed ID: 3373485
[TBL] [Abstract][Full Text] [Related]
18. Studies of platelet activating factor (PAF) antagonists from microbial products. III. Pharmacological studies of FR-900452 in animal models.
Okamoto M; Yoshida K; Nishikawa M; Hayashi K; Uchida I; Kohsaka M; Aoki H
Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):3005-10. PubMed ID: 3769104
[No Abstract] [Full Text] [Related]
19. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
20. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
